Potential risk of neurodevelopmental disorders in children born to men treated with valproate medicines: PRAC recommends precautionary measures
EMA’s safety committee (PRAC) is recommending precautionary measures for the treatment of male patients with valproate medicines. 
      
                    News
                    Human
                    Pharmacovigilance
                    Referrals